AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
41 hedge funds and large institutions have $86.5M invested in Agile Therapeutics in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Holders
41
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.93M | |
| 2 | +$765K | |
| 3 | +$488K | |
| 4 |
Goldman Sachs
New York
|
+$309K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$307K |
Top Sellers
| 1 | -$2.18M | |
| 2 | -$1M | |
| 3 | -$512K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$450K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$285K |